Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases

British Journal of Cancer

Volumn 102, Issue 4, 2010, Pages 774-782

  Ishiguro, T ^a   Avila, H ^a   Lin, S Y ^a   Nakamura, T ^b   Yamamoto, M ^c   Boyd, D D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chloride channel 4; Colorectal cancer; Enhanced retroviral mutagenesis; Invasion; Microenvironment; Migration

Indexed keywords

ANTIPORTER; CHLORIDE CHANNEL; CHLORIDE CHANNEL 4; COMPLEMENTARY DNA; HEMAGGLUTININ; PROTON; TETRACYCLINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CLONE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; ENHANCED RETROVIRAL MUTAGEN; GENE AMPLIFICATION; GENE CASSETTE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; LIVER METASTASIS; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS; RNA SPLICING; STABLE EXPRESSION;

ADENOCARCINOMA; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHLORIDE CHANNELS; CLONING, MOLECULAR; COLONIC NEOPLASMS; DISEASE PROGRESSION; HCT116 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 76949092767     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605536     Document Type: Article

References (34)

1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Coppola D, Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profile. J Natl Cancer Inst 94: 513-521
2. KIP1. Mol Cell Biol 17: 3850-3857
3. Brattain MG, Brattain DE, Fine WD, Khaled FM, Marks ME, Kimball PM, Arcolano LA, Danbury BH (1981) Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts. Oncodev Biol Med 2: 355-366
4. Brattain MG, Levine A, Chakrabarty S, Yeoman L, Willson J, Long B (1984) Heterogeneity of human colon carcinoma. Cancer Metastasis Rev 3: 177-191
5. 2+-activated chloride channel genes CLCA1 and CLCa2 is downregulated in human colorectal cancer. DNA Cell Biol 20: 331-338
6. Cajot JF, Sordat I, Silvestre T, Sordat B (1997) Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57: 2593-2597
7. Chapman JM, Knoepp JM, Byeon SM, Kyeong M, Henderson KW, Schweinfest CW (2002) The colon anion transporter, down-regulated in adenoma, induces growth suppression that is abrogated by E1A. Cancer Res 62: 5083-5088
8. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev 4: 769-780
9. Derynck R, Akhurst RJ, Balmain A (2001) TGF-b signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129
10. Ding XW, Yan JJ, An P, Lu P, Luo HS (2007) Aberrant expression of ether a go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol 13: 1257-1261
11. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis. Nat Rev 4: 891-899
12. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer res 60: 749-755
13. Heyer J, Yang K, Lipkin M, Edelmann W, Kucherlapati R (1999) Mouse models for colorectal cancer. Oncogene 18: 5325-5333
14. Jentsch TJ (2008) CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol 43: 3-36
15. Jessup J, Giavazzi R, Campbell D, Cleary KR, Morikawa K, Hostetter R, Atkinson EN, Fidler IJ (1989) Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure. Cancer Res 49: 6906-6910
16. Kahan BD, Rutzky L, Berlin B, Tomita J, Wiseman F, LeGrue S, Noll H, Tom BH (1976) Cell alterations on colon adenocarcinoma cells. Cancer Res 36: 3526-3634
17. Koslowski M, Sahin U, Dhaene K, Huber C, Tureci O (2008) MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. Cancer Res 68: 3458-3466
18. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
19. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa J-PI, Willis J, Willson JK, Markowitz S (2003) SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci USA 100: 8412-8417
20. Lin S-Y, Elledge SJ (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881-889
21. Liu D, yang X, Yang D, Songyang Z (2000) Genetic screens in mammalian cells by enhanced retroviral mutagens. Oncogene 19: 5964-5972
22. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC (1999) Loss of KAI-1 expression in the progression of colorectal cancer. Cancer Res 59: 5724-5731
23. Minard ME, Herynk MH, Collard JG, Gallick GE (2005) The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24: 2568-2573
24. Mohammad-Panah R, Ackerley C, Rommens J, Choudhury M, Wang Y, Bear CE (2002) The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia. J Biol Chem 277: 566-574
25. Mohammad-Panah R, Wellhauser L, Steinberg BE, Wang Y, Huan LJ, Liu X-D, Bear CE (2009) An essential role for ClC-4 in transferring receptor function revealed in studies of fibroblasts derived from Clcn4-null mice. J Cell Sci 122: 1229-1237
26. Montcourrier P, Mangeat PH, Valembois C, Salazar G, Sahuquet A, Duperray C, Rochefort H (1994) Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci 107: 2381-2391
27. Picollo A, Pusch M (2005) Chloride/proton antiporter activity of mammalian CLC proteins Clc-4 and Clc-5. Nature 436: 420-423
28. Ransom CB, O'Neal JT, Sontheimer H (2001) Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 21: 7674-7683
29. Samuels Y, Diaz LA, Schmidt-Kittler O, Cummins JM, DeLong L, Chong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561-573
30. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B, Velcelescu VE (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554 (Pubitemid 38541907)
31. Sordat I, Decraene C, Silvestre T, Petermann O, Auffray C, Piffanelli A, Sordat B (2002) Complementary DNA arrays identify CD63 tetaspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells. Lab Invest 82: 1715-1724
32. Soroceanu L, Manning T, Sontheimer H (1999) Modulation of glioma cell migration and invasion using Cl-and K+ ion channel blockers. J Neurosci 19: 5942-5954
33. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Kemp z, Spain S, Penegar S, Chandler I, Gorman M, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Corgi C, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier J-B, Houlston R (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39: 984-988
34. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113